#cardiovascular

As people with HIV live longer thanks to effective antiretroviral treatment, they are prone to a host of additional health problems.

High blood pressure, diabetes, lung disease and cardiovascular disease are all more prevalent among women with HIV.

The REPRIEVE study, which is primarily looking at a statin’s effect on cardiovascular disease, is shedding light on many other mysteries.

Hypertension raises the risk of heart disease and severe COVID-19.

Tight living spaces, lack of protective gear and preexisting health conditions may account for the higher death rate in prisons.

People with cancer, heart disease and diabetes are at increased risk for serious illness from COVID-19.

A rundown of POZ’s reporting on the 2020 Conference on Retroviruses and Opportunistic Infections

A recent Swedish study defined a low-level detectable viral load as between 50 and 999.

The association between viral load and cardiovascular disease risk has been under-investigated among young people with HIV.

This finding, which is in keeping with initial studies out of China and Italy, is preliminary as the CDC continues to gather data.

A recent study finds that people with HIV receive insufficient attention to cardiovascular risk.

Lower rates of targeted interventions and care strategies for acute heart problems compared with HIV-negative people are a likely factor.

Attendees will hear news about the second probable HIV cure, long-acting injectable meds and COVID-19.